COMMON WARTS (VERRUCA VULGARIS)
Clinical trials for COMMON WARTS (VERRUCA VULGARIS) explained in plain language.
Never miss a new study
Get alerted when new COMMON WARTS (VERRUCA VULGARIS) trials appear
Sign up with your email to follow new studies for COMMON WARTS (VERRUCA VULGARIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a blister beetle extract banish common warts? phase 3 trial investigates
Disease control Not yet recruitingThis Phase 3 trial tests YCANTH, a topical solution containing cantharidin (a substance from blister beetles), against a placebo for treating common warts. About 300 people aged 2 and older with at least one wart on their body (excluding certain areas) will receive either the act…
Matched conditions: COMMON WARTS (VERRUCA VULGARIS)
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Wart war: blood clot vs vitamin jab – which works best?
Symptom relief Not yet recruitingThis study tests two injection treatments for common warts: one using a patient's own blood components (platelet-rich fibrin) and the other using vitamin D. About 70 adults with warts will receive one of the two injections. The goal is to see which treatment shrinks warts more an…
Matched conditions: COMMON WARTS (VERRUCA VULGARIS)
Phase: NA • Sponsor: Sohag University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC